(Q37779320)

23 August 2017

1 reference

title

Effects of herbal products on the metabolism and transport of anticancer agents (English)

1 reference

23 August 2017

Shu-Ming He

1

1 reference

23 August 2017

An-Kui Yang

2

1 reference

23 August 2017

Xiao-Tian Li

3

1 reference

23 August 2017

Yao-Min Du

4

1 reference

23 August 2017

Shu-Feng Zhou

5

1 reference

23 August 2017

language of work or name

English

0 references

publication date

1 October 2010

1 reference

Expert Opinion on Drug Metabolism & Toxicology

23 August 2017

published in

1 reference

23 August 2017

volume

6

1 reference

23 August 2017

issue

10

1 reference

23 August 2017

page(s)

1195-1213

1 reference

A change of strategy in the war on cancer.

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

Targeted therapies: the rare cancer paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

Timeline: Chemotherapy and the war on cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

Pharmacokinetic variability of anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

Modulation of cytochrome P450 activity: implications for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

Why is cancer drug discovery so difficult?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

Drug resistance in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

Identification and exploration of herb-drug combinations used by cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

The prevalence of complementary/alternative medicine in cancer: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

Herbal remedies in the United States: potential adverse interactions with anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

Effect of garlic on total serum cholesterol. A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

Potential health risks of complementary alternative medicines in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

The escalating cost and prevalence of alternative medicine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

Herb-drug interactions: a literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

Herb-drug interactions in oncology: focus on mechanisms of induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

Herbal interactions with anticancer drugs: mechanistic and clinical considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

Herbs and cytotoxic drugs: recognizing and communicating potentially relevant interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

Complications of traditional Chinese/herbal medicines (TCM)--a guide for perplexed oncologists and other cancer caregivers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

Drug interactions in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

The use of herbal medicines by people with cancer: a qualitative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

Safety and efficacy of herbal sedatives in cancer care

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

Herbal medicine in the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

Botanical medicines for the treatment of cancer: rationale, overview of current data, and methodological considerations for phase I and II trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

A double-blind placebo-controlled randomized study of Chinese herbal medicine as complementary therapy for reduction of chemotherapy-induced toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

Botanical medicine and cancer: a review of the safety and efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

The role of complementary and alternative medicine in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

Enzyme-catalyzed activation of anticancer prodrugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

Interactions of herbs with cytochrome P450.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

The human ATP-binding cassette (ABC) transporter superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

Topotecan is a substrate for multidrug resistance associated protein 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

Functions of the breast cancer resistance protein (BCRP/ABCG2) in chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

MRP3, an organic anion transporter able to transport anti-cancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

Transport of cyclic nucleotides and estradiol 17-beta-D-glucuronide by multidrug resistance protein 4. Resistance to 6-mercaptopurine and 6-thioguanine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

The multidrug resistance protein 5 functions as an ATP-dependent export pump for cyclic nucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

Association of high-level MRP1 expression with poor clinical outcome in a large prospective study of primary neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

A mutation in the drug transporter gene ABCC2 associated with impaired methotrexate elimination

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

ABC of oral bioavailability: transporters as gatekeepers in the gut.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

Substrates and inhibitors of human multidrug resistance associated proteins and the implications in drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

Effects of St. John's wort on irinotecan metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

Effect of milk thistle (Silybum marianum) on the pharmacokinetics of irinotecan

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

Pharmacokinetic interaction between ketoconazole and imatinib mesylate (Glivec) in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

A benefit-risk assessment of imatinib in chronic myeloid leukaemia and gastrointestinal stromal tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

Metabolism and disposition of imatinib mesylate in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

Influence of CYP3A4 inhibition on the steady-state pharmacokinetics of imatinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

Effect of St John's wort on imatinib mesylate pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

The influence of St. John's wort on the pharmacokinetics and protein binding of imatinib mesylate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

Docetaxel. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

Influence of garlic (Allium sativum) on the pharmacokinetics of docetaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

A mechanistic study on altered pharmacokinetics of irinotecan by St. John's wort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

St. John's Wort modulates the toxicities and pharmacokinetics of CPT-11 (irinotecan) in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

An update on clinical drug interactions with the herbal antidepressant St. John's wort

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

The nuclear xenobiotic receptor pregnane X receptor: recent insights and new challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

St Johns wort increases expression of P-glycoprotein: implications for drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

Saint John's wort: an in vitro analysis of P-glycoprotein induction due to extended exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

Coordinate induction of both cytochrome P4503A and MDR1 by St John's wort in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

CYP3A and P-glycoprotein activity induction with St. John's Wort in healthy volunteers from 6 ethnic populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

Effect of St John's wort on the pharmacokinetics of fexofenadine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

Alterations in cyclosporin A pharmacokinetics and metabolism during treatment with St John's wort in renal transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

Interaction of imatinib mesilate with human P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

High-affinity interaction of tyrosine kinase inhibitors with the ABCG2 multidrug transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

Interaction of imatinib with human organic ion carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

The effect of P-gp (Mdr1a/1b), BCRP (Bcrp1) and P-gp/BCRP inhibitors on the in vivo absorption, distribution, metabolism and excretion of imatinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

Clinical drugs that interact with St. John's wort and implication in drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

Pharmacokinetic interactions of drugs with St John's wort

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

Mechanism-based inhibition of cytochrome P450 3A4 by therapeutic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

Modulation of the activity of ABC transporters (P-glycoprotein, MRP2, BCRP) by flavonoids and drug response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

Herbal modulation of P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

Identification of drugs that interact with herbs in drug development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

Role for protein kinase C delta in the functional activity of human UGT1A6: implications for drug-drug interactions between PKC inhibitors and UGT1A6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

Drug-drug interactions of silymarin on the perspective of pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

Effects of dietary ingredients on function and expression of P-glycoprotein in human intestinal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

Effects of dietary chemopreventive phytochemicals on P-glycoprotein function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

Effects of spice constituents on P-glycoprotein-mediated transport and CYP3A4-mediated metabolism in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

Aged garlic extract stimulates p-glycoprotein and multidrug resistance associated protein 2 mediated effluxes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

Reversal of P-glycoprotein-mediated multidrug resistance by protopanaxatriol ginsenosides from Korean red ginseng

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

Inhibition of multidrug resistance proteins MRP1 and MRP2 by a series of alpha,beta-unsaturated carbonyl compounds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

Metabolites of ginsenosides as novel BCRP inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

Phytochemicals induce breast cancer resistance protein in Caco-2 cells and enhance the transport of benzo[a]pyrene-3-sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

Inhibitory effects of herbal extracts on breast cancer resistance protein (BCRP) and structure-inhibitory potency relationship of isoflavonoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

Membrane transporters and channels: role of the transportome in cancer chemosensitivity and chemoresistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2010.510132

10.1517/17425255.2010.510132

21 January 2018

Identifiers

DOI

1 reference

23 August 2017

1 reference